Major Smith & Nephew investors call for break-up of medical device maker healthcare Three of Smith & Nephew's biggest shareholders are reportedly urging the FTSE 100 firm to break up if it cannot improve performance.
Smith & Nephew hits back at claims it massaged profit margins healthcare Embattled hip and knee implant maker Smith & Nephew has hit back at a report claiming that it deployed aggressive accounting techniques to bolster its profit margins.
Growing demand for hip and knee replacements help Smith and Nephew to growth industrials Orthopaedic sales grew by 4.4 per cent over the quarter, thanks to "growth in hip and knee implants outside the US."
Smith and Nephew lifts outlook as medical device revenue growth offsets China slowdown February 27, 2024 It wasn't all plain sailing for the medical tech giant however, with its operating profit for the year down to £335m, from £356m.
